HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 98/6/2108    most recent 01371.2004v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Rubio, J. C. Articles by Lucia, A. Search for Related Content PubMed PubMed Citation Articles by Rubio, J. C. Articles by Lucia, A.

Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance?

¹Research Centre, University Hospital 12 de Octubre; ²Department of Physiology, Sport Medicine Center, Higher Sports Council; ³European University of Madrid; ⁴Medical Department, Spanish Track and Field Federation; and ⁵Complutense University, Madrid, Spain

Submitted 13 December 2004 ; accepted in final form 20 January 2005

The C34T mutation in the gene encoding for the skeletal muscle-specific isoform of AMP deaminase (AMPD1) is a common mutation among Caucasians (i.e., one of five individuals) that can impair exercise capacity. The purpose of this study was twofold. First, we determined the frequency distribution of the C34T mutation in a group of top-level Caucasian (Spanish) male endurance athletes (cyclists and runners, n = 104). This group was compared with randomly selected Caucasian (Spanish) healthy (asymptomatic) nonathletes (n = 100). The second aim of this study was to compare common laboratory indexes of endurance performance (maximal oxygen uptake or ventilatory thresholds) within the group of athletes depending on their C34T AMPD1 genotype. The frequency of the mutant T allele was lower (P < 0.05) in the group of athletes (4.3%) compared with controls (8.5%). On the other hand, indexes of endurance performance did not differ (P > 0.05) between athlete carriers or noncarriers of the C34T mutation (e.g., maximal oxygen uptake 72.3 ± 4.6 vs. 73.5 ± 5.9 ml·kg^–1·min^–1, respectively). In conclusion, although the frequency distribution of the mutant T allele of the AMPD1 genotype is lower in Caucasian elite endurance athletes than in controls, the C34T mutation does not significantly impair endurance performance once the elite-level status has been reached in sports.

AMP deaminase; cycling; running

This article has been cited by other articles:

				M Gonzalez-Freire, C Santiago, Z Verde, J I Lao, J OIivan, F Gomez-Gallego, and A Lucia Unique among unique. Is it genetically determined? Br. J. Sports Med., April 1, 2009; 43(4): 307 - 309. [Abstract] [Full Text] [PDF]

				J. R. Ruiz, F. Gomez-Gallego, C. Santiago, M. Gonzalez-Freire, Z. Verde, C. Foster, and A. Lucia Is there an optimum endurance polygenic profile? J. Physiol., April 1, 2009; 587(7): 1527 - 1534. [Abstract] [Full Text] [PDF]

				A. Lucia, M. A Martin, J. Esteve-Lanao, A. F S. Juan, J. C Rubio, J. Olivan, and J. Arenas C34T mutation of the AMPD1 gene in an elite white runner BMJ Case Reports, January 22, 2009; 2009(jan21_1): bcr0720080535 - bcr0720080535. [Abstract] [Full Text]

				A. G. Williams and J. P. Folland Similarity of polygenic profiles limits the potential for elite human physical performance J. Physiol., January 1, 2008; 586(1): 113 - 121. [Abstract] [Full Text] [PDF]

				A Lucia, M A Martin, J Esteve-Lanao, A F San Juan, J C Rubio, J Olivan, and J Arenas C34T mutation of the AMPD1 gene in an elite white runner. Br. J. Sports Med., March 1, 2006; 40(3): e7 - e7. [Abstract] [Full Text] [PDF]